One hundred patients were entered in a cooperative study comparing the efficacy of two different regimens in the induction treatment of acute nonlymphocytic leukemia (ANLL). Patients were randomly allocated to receive either the DAT or VAT combination; half of the patients were also randomized to re
Daunorubicin, cytosine arabinoside and 6-thioguanine (DAT) combination chemotherapy for the treatment of acute non-lymphocytic leukemia
โ Scribed by Sergio Amadori; Giuseppe Papa; Giovanna Meloni; Leonardo Pacilli; Franco Mandelli
- Book ID
- 113237931
- Publisher
- Elsevier Science
- Year
- 1979
- Tongue
- English
- Weight
- 397 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0145-2126
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
In this study 523 previously untreated patients with acute myelocytic leukemia were randomly allocated to induction therapy with daunorubicin 60 mg/M2 daily X 3, cytosine arabinoside and thioguanine 100 mg/M2 each every 12 hours until marrow hypoplasia was achieved, or a 5-day course of the three dr
One hundred-sixty-three children with acute nonlymphocytic leukemia (ANLL) were treated with a multiple-drug induction program (PATCO) consisting of prednisone (PDN), cytosine arabinoside ((Ara-C), 6-thioguanine (6-TG), cyclophosphamide (CPM), and Oncovin (VCR). Ninety-six, 59%, obtained a remission